Evidence map›Paper›PMID 17253130›Full record

ArticleDigestive diseases and sciences2007

Deoxycholate-induced colitis is markedly attenuated in Nos2 knockout mice in association with modulation of gene expression profiles.

Harris Bernstein, Hana Holubec, Carol Bernstein, Natalia A Ignatenko, Eugene Gerner, Katerina Dvorak, David Besselsen, Karen Ann Blohm-Mangone, Jose Padilla-Torres, Barbora Dvorakova and 2 more

Abstract readComparative Study
PubMed Publisher
In one paragraph

Article in Digestive diseases and sciences, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 26 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. ABIN1 alleviates inflammatory responses and colitisTherapeutic advances in chronic disease · 2020
    Article
  6. Organic Solute Transporter α-β Protects Ileal Enterocytes From Bile Acid-Induced Injury.Cellular and molecular gastroenterology and hepatology · 2018
    Article
  7. Article
  8. Article
  9. Targeting polyamines and inflammation for cancer prevention.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2011
    Review
  10. Article
  11. Article
  12. Current concepts in colorectal cancer prevention.Expert review of gastroenterology & hepatology · 2009
    Review
  13. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation.Clinical cancer research : an official journal of the American Association for Cancer Research · 2009
    Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Harris BernsteinDepartment of Cell Biology and Anatomy, College of Medicine, University of Arizona, Tucson, Arizona 85724-5044, USA. bernstein3@earthlink.net
Hana Holubec
Carol Bernstein
Natalia A Ignatenko
Eugene Gerner
Katerina Dvorak
David Besselsen
Karen Ann Blohm-Mangone
Jose Padilla-Torres
Barbora Dvorakova
Harinder Garewal
Claire M Payne
University of Arizona · USUniversity of Arizona Cancer Center

Funding

VITAMIN AP30CA023074 · NCI · UNIVERSITY OF ARIZONA · PI Justin M Snider · 1985 to 2026
$110.2M
SPORE in Gastrointestinal CancerP50CA095060 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 2002 to 2012
$25.3M
RESISTANCE TO BILE ACID INDUCED APOPTOSISP01CA072008 · NCI · UNIVERSITY OF ARIZONA · PI GERNER, EUGENE W · 1997 to 2005
$6.9M
Cytochrome C Oxidase I:A Biomarker for Colon Cancer RiskR21CA111513 · NCI · UNIVERSITY OF ARIZONA · PI PAYNE, CLAIRE MARGARET · 2005 to 2006
$256k
NCI NIH HHS 1P50CA95060-01NCI NIH HHS 1R21CA111513-01A1NCI NIH HHS CA23074NCI NIH HHS CA72008NCI NIH HHS P01 CA072008
6 · The paper itself

Abstract

Nos2 knockout mice were compared to wild-type mice for susceptibility to colitis in response to a diet supplemented with deoxycholate, a bile acid increased in the colon of individuals on a high-fat diet. Wild-type mice fed a fat-related diet, supplemented with 0.2% DOC, develop colonic inflammation associated with increases in nitrosative stress, proliferation, oxidative DNA/RNA damage, and angiogenesis, as well as altered expression of numerous genes. However, Nos2 knockout mice fed a diet supplemented with deoxycholate were resistant to these alterations. In particular, 35 genes were identified whose expression was significantly altered at the mRNA level in deoxycholate-fed Nos2(+/+) mice but not in deoxycholate-fed Nos2(-/-) mice. Some of these alterations in NOS2-dependent gene expression correspond to those reported in human inflammatory bowel disease. Overall, our results indicate that NOS2 expression is necessary for the development of deoxycholate-induced colitis in mice, a unique dietary-related model of colitis.

Indexed as

Gene Expression ProfilingAnimalsColitisDeoxycholic AcidDetergentsDietary SupplementsDisease Models, AnimalDisease ProgressionDNA DamageImmunohistochemistryIntestinal MucosaMembrane ProteinsMiceMice, Inbred StrainsNitric Oxide SynthaseOligonucleotide Array Sequence AnalysisDeoxycholic AcidDetergentsMembrane ProteinsNitric Oxide Synthase

Identifiers

PMID17253130
OpenAlexW2022320739

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.